The RapidFor™ SARS-CoV-2 Rapid Antigen Test Kit uses the colloidal label as a tool for SARS-CoV-2 antigen detection in the collected nasopharyngeal, nasal, and oropharyngeal specimens.
– Easy to use and read
– No extra lab equipment
– Variant Detection [B.1.1.7 (Alpha), B.1.351 (Beta), E484K mutation,
B1.617.2 (Delta), P.1 (Gamma), C.37 (Lambda), B.1.1.529 (Omicron) ]
– Early phase detection
– Easy to store and transport
– Test Cassette
– Extraction Buffer
– User Manual
|Intended use||Detection of SARS-CoV-2 antigen|
|Storage||2-30℃ / 35.6-86℉|
|Time to result||15 minutes|
|Shelf life||24 months|
Clinical performance of the kit varies depending on the type of specimen analyzed. With nasopharyngeal swabs, RapidFor™ Rapid Antigen Test Kit has demonstrated 97.3% sensitivity, 99.05% specificity, and 98.09% overall accuracy.
With nasal swabs, RapidFor™ Rapid Antigen Test Kit has demonstrated 97.05% sensitivity, 99.23% specificity, and 97.99% overall accuracy. With oropharyngeal swabs, RapidFor™ Rapid Antigen Test Kit has demonstrated 95.30% sensitivity, 100% specificity, and 97.19% overall accuracy. Moreover, no cross-reactivity or interference was observed with any of the substances and pathogens tested.
Yes, RapidFor™ Rapid Antigen Test Kit can successfully detect infections with SARS-CoV-2 as early as 3-7 days after viral exposure.
RapidFor™ Rapid Antigen Test Kit is suitable for use in a wide range of areas including schools, workplaces, clinics, laboratories, airports, and hotels, along with various forms of care, congregate, and confinement facilities.
Our examinations have shown that our test kits can detect current variants of SARS-CoV-2, including B.1.1.7 UK (Alpha), B.1.351 South Africa (Beta), E484K mutation, B1.617.2 India (Delta), P.1 Brazil (Gamma), C.37 (Lambda), and B.1.1.529 (Omicron) strains.
RapidFor™ Rapid Antigen Test Kit offers many unique benefits for public health. Unlike RT-PCR tests, RapidFor™ Rapid Antigen Test Kit can detect infections with SARS-CoV-2 in just a few minutes, which reduces turnaround time, ensures immediate isolation, prevents further transmission, and aids the initiation of optimal treatment.
RapidFor™ Rapid Antigen Test Kit allows for safe, non-invasive, and pain-free sample collection with user-friendly nasal, nasopharyngeal, and oropharyngeal swabs. Please follow the instructions carefully in order to ensure maximum safety, comfort, and accuracy. While mild discomfort is possible during sample collection, make sure to stop the procedure and seek medical help if you experience any pain.
Please read the instructions thoroughly before starting the procedure. The procedure should be concluded within 15 minutes after the test cassette is removed from the foil package. Please make sure to recap the buffer solution quickly after each use and utilize the sample as soon as possible. The sample should be used within 20 minutes at most, inactivation of samples is not recommended.
A negative test result with RapidFor™ Rapid Antigen Test Kit does not completely exclude an infection with SARS-CoV-2. Complementary testing with RT-PCR tests may be required to rule out the risk of an active infection.
A positive result with RapidFor™ Rapid Antigen Test Kit is indicative of active infection with SARS-CoV-2. Please go into quarantine and contact your healthcare provider. A confirmatory test by using an RT-PCR test may be necessary.
No, RapidFor™ Rapid Antigen Test Kit is designed for one-time use only.
After the process, all samples and materials should be placed in the aluminum foil and disposed of as biohazardous waste as soon as possible. Please refrain from using the recycling bin for disposal and make sure that animals and children are out of reach.
RapidFor™ Rapid Antigen Test Kit can be stored be between 2°C-30°C and within 40-60% of humidity in the sealed package until its expiration date. Please make sure to check the label on the packaging for the manufacturing and expiration dates. Do not store the kit below 2°C or use it after expired date.